119th Congress · House
HR. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
reported
Introduced 2025-09-15•Latest 2025-09-17
Origin chamber
House
Cosponsors
13
Latest action
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Subjects
Congressional oversightDrug safety, medical device, and laboratory regulationHealthHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesMedicare
Key actions
- Committee Consideration and Mark-up Session Held
- Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
- Introduced in House
- Introduced in House
- Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill text versions
Related bills
No related bills listed.